Clearstead Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$115K	Buy	411 +408	+13,600%	+$118K	﹤0.01%	1111
2025 Q4	$909	Buy	+3	New	+$936	﹤0.01%	2236
2025 Q2	–	Sell	-3	Closed	-$731	–	2747
2025 Q1	$731	Sell	3 -66	-96%	-$19.9K	﹤0.01%	2027
2024 Q4	$22.7K	Sell	69 -133	-66%	-$45.1K	﹤0.01%	1345
2024 Q3	$67.6K	Hold	202	–	–	﹤0.01%	1134
2024 Q2	$55.2K	Buy	202 +74	+58%	+$21.5K	﹤0.01%	1140
2024 Q1	$36.5K	Buy	128 +18	+16%	+$5.92K	﹤0.01%	836
2023 Q4	$35.5K	Sell	110 -130	-54%	-$40.7K	﹤0.01%	824
2023 Q3	$86K	Buy	240 +53	+28%	+$20.4K	﹤0.01%	768
2023 Q2	$70.9K	Buy	187 +67	+56%	+$27.3K	﹤0.01%	656
2023 Q1	$57.5K	Buy	+120	New	+$56.2K	﹤0.01%	632
2022 Q2	–	Sell	-20	Closed	-$11K	–	1285
2022 Q1	$11K	Buy	+20	New	+$12.1K	﹤0.01%	971
2021 Q3	–	Sell	-3	Closed	-$2K	–	1292
2021 Q2	$2K	Buy	+3	New	+$1.83K	﹤0.01%	1022
2021 Q1	–	Sell	-22	Closed	-$13K	–	1116
2020 Q4	$13K	Hold	22	–	–	﹤0.01%	682
2020 Q3	$11K	Hold	22	–	–	﹤0.01%	650
2020 Q2	$10K	Hold	22	–	–	﹤0.01%	600
2020 Q1	$8K	Buy	+22	New	+$8.09K	﹤0.01%	590